Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up-Reference-Cited by-同舟云学术

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up

Published:2002-04 Issue:9315 Volume:359 Page:1379-1387
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels;Sacks;N Engl J Med,1996

3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels;N Engl J Med,1998

4. Design features and baseline characteristics of the LIPID (Long-term Intervention with Pravastatin in Ischaemic Disease) study: a randomised trial in patients with previous acute myocardial infarction and/or unstable angina pectoris;Am J Cardiol,1995

5. Long-term risk stratification for survivors of acute coronary syndromes: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study;Marschner;J Am Coll Car dial,2001

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin‐Resistant Rats: Acute Treatment Versus Long‐Term Protection as an Idiotypic Vaccine for Atherosclerosis;Journal of the American Heart Association;2024-07-02

2. Significance of Persistent Inflammation in Patients With Chronic Coronary Syndrome;JACC: Advances;2024-07

3. Evolocumab Treatment in Dyslipidemic Patients Undergoing Coronary Artery Bypass Grafting: One-Year Safety and Efficacy Results;Journal of Clinical Medicine;2024-05-19

4. Prevention of preeclampsia;Best Practice & Research Clinical Obstetrics & Gynaecology;2024-03

5. Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins;Frontiers in Cardiovascular Medicine;2024-01-15